Table 5.
The pre- and post-vaccination humoral and cellular immune responses in SARS-CoV-2-naïve individuals.
| Vaccines | SARS-CoV-2 S1 IgG ELISA (Ratio) | pVNT (pVNT50) |
IFN-γ ELISpot (SFC/2.5 × 105 Cells) |
|||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| Ad26.COV2.S | 0.2 ± 0.3 | 1.4 ± 0.8 | 10 | 31 ± 56 | 7.4 ± 9.1 | 9.8 ± 14.5 |
| ChAdOx1 | 0.1 ± 0.0 | 5.6 ± 2.7 | 10 | 96 ± 90 | 8.0 ± 8.9 | 11.2 ± 17.2 |
| ChAdOx1/ BNT162b2 |
0.1 ± 0.1 | 8.0 ± 1.3 | 10 | 206 ± 111 | 10.9 ± 5.8 | 75.2 ± 85.8 |
| BNT162b2 | 0.1 ± 0.1 | 10.2 ± 1.2 | 10 | 355 ± 384 | 5.3 ± 6.4 | 15.9 ± 18.7 |
| mRNA-1273 | 0.3 ± 0.4 | 11.3 ± 1.0 | 10 | 406 ± 200 | 6.5 ± 6.6 | 18.9 ± 27.4 |